In this study, we have demonstrated, using two different experimental approaches, that the PPP which is specifically elevated during cell cycle progression in the highly proliferating advanced human adenocarcinoma cell line HT-29 [28,29] is further elevated by IGF-1 but suppressed by the bioactive compound RSV. The gene discussed is IGF1; the disease is adenocarcinoma.